Adherium Limited logo

Adherium Limited (ADR)

Market Closed
CXA CXA
- Market Cap
- P/E Ratio
- Div Yield
1,500 Volume
0 Eps
Want to track ADR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ADR is not paying dividends to its shareholders.
Adherium Limited has completed 2 stock splits, with the recent split occurring on Jun 26, 2025.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on CXA (AUD).

Adherium Limited (ADR) FAQ

On which exchange is it traded?

Adherium Limited is listed on CXA.

What is its stock symbol?

The ticker symbol is ADR.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Adherium Limited ever had a stock split?

Adherium Limited had 2 splits and the recent split was on Jun 26, 2025.

Adherium Limited Profile

Biotechnology Industry
Healthcare Sector
Mr. Louis James Panaccio BEC, C.A., M.A.I.C.D. CEO
CXA Exchange
- ISIN
Australia Country
- Employees
- Last Dividend
4 Dec 2023 Last Split
- IPO Date

Overview

Adherium Limited is a pioneer in the digital health technology sector, dedicated to addressing the challenges of sub-optimal medication usage in chronic diseases. With operations spanning New Zealand, Australia, Europe, and North America, the company has made significant strides since its inception in 2001. Based in Melbourne, Australia, Adherium is at the forefront of developing, manufacturing, and supplying innovative solutions aimed at enhancing patient adherence to medication regimens, particularly for chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Their commitment to healthcare innovation positions them as key players in improving patient outcomes and quality of life.

Products and Services

Adherium’s product lineup is centered around Hailie, a comprehensive asthma and COPD medication adherence tool, designed with the patient's needs in mind. Each offering is tailored to facilitate better management of chronic respiratory diseases through enhanced medication adherence and real-time patient feedback.

  • Hailie - Hailie is the cornerstone of Adherium’s product suite, designed as an adherence solution for individuals with asthma and COPD. It aims to improve patients' quality of life by ensuring they stay on top of their medication regimen. Hailie is supported by a range of digital tools, making medication management easier and more effective for patients.
  • Bluetooth Enabled Hailie Sensors - These sensors are an integral part of the Hailie solution, designed to wrap around patients' inhalers. They seamlessly capture and transmit usage data, ensuring doses are taken correctly and at the right times. The real-time feedback mechanism is a critical feature, empowering patients to adhere to their prescribed medication schedules effectively.
  • Hailie App - The Hailie app is a companion mobile application for patients using the Hailie sensor. It provides users with easy access to their medication usage data, offers reminders, and tracks adherence over time. This personal adherence data helps patients and their healthcare providers to make informed decisions about their treatment plans.
  • Hailie Portal - Aimed primarily at healthcare providers, the Hailie portal is a web-based platform that allows for efficient monitoring and management of patient medication adherence. It offers detailed insights into patients’ adherence patterns, facilitating more targeted and effective patient care.
  • Hailie Remote Patient Management Solution - This service extends the capability of the Hailie ecosystem, providing a comprehensive solution for healthcare providers to remotely monitor and support their patients’ medication adherence. It is an essential tool for achieving better health outcomes in chronic disease management.

Contact Information

Address: 447 Collins Street
Phone: 64 9 307 2771